Loading live market data…

Akero Therapeutics, Inc.

NASDAQ:AKRO

$54.65 USD

$0 (0.0%)

Volume
11.61M
Average Volume
2.56M
Market Capitalization
$4.5B
P/E Ratio
-19.87
Dividend Yield
0.00%
Price Target
$54.00
Year High
$58.40
Year Low
$21.34
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$15.83
Source Headline

Get AKRO Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

AKRO Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$59.00

4 analysts

All Time

$51.00

10 analysts

AKRO Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-10-10 Wolfe Research Downgrade Outperform Peer Perform
2025-10-10 HC Wainwright & Co. Downgrade Buy Neutral
2025-10-09 Jefferies Downgrade Buy Hold
2025-10-09 Canaccord Genuity Downgrade Buy Hold
2025-05-27 B of A Securities Maintain Buy Buy
2025-05-13 Citigroup Maintain Buy Buy
2025-03-03 HC Wainwright & Co. Maintain Buy Buy
2025-01-31 UBS Maintain Buy Buy
2025-01-30 B of A Securities Upgrade Neutral Buy
2025-01-27 HC Wainwright & Co. Maintain Buy Buy
2025-01-16 HC Wainwright & Co. Maintain Buy Buy
2024-11-18 HC Wainwright & Co. Maintain Buy Buy
2024-11-11 HC Wainwright & Co. Maintain Buy Buy
2024-08-12 HC Wainwright & Co. Maintain Buy Buy
2024-06-11 HC Wainwright & Co. Maintain Buy Buy
2024-05-15 Evercore ISI Group Maintain Outperform Outperform
2024-05-13 Canaccord Genuity Maintain Buy Buy
2024-05-13 HC Wainwright & Co. Maintain Buy Buy
2024-03-05 HC Wainwright & Co. Maintain Buy Buy
2024-03-05 UBS Maintain Buy Buy
2024-03-01 HC Wainwright & Co. Maintain Buy Buy
2023-11-14 HC Wainwright & Co. Maintain Buy Buy
2023-10-12 UBS Maintain Buy Buy
2023-10-11 Morgan Stanley Maintain Overweight Overweight
2023-10-11 Cantor Fitzgerald Maintain Overweight Overweight
2023-10-11 JP Morgan Maintain Overweight Overweight
2023-10-11 HC Wainwright & Co. Maintain Buy Buy
2023-10-04 Cantor Fitzgerald Maintain Overweight Overweight
2023-09-13 Evercore ISI Group Maintain Outperform Outperform
2023-09-05 JP Morgan Maintain Overweight Overweight
2023-06-12 Morgan Stanley Maintain Overweight Overweight
2023-06-07 HC Wainwright & Co. Maintain Buy Buy
2023-05-17 Canaccord Genuity Maintain Buy Buy
2023-05-16 HC Wainwright & Co. Maintain Buy Buy
2023-03-21 Canaccord Genuity Maintain Buy Buy
2023-03-20 HC Wainwright & Co. Maintain Buy Buy
2023-01-27 Morgan Stanley Upgrade Equal Weight Overweight
2022-11-07 HC Wainwright & Co. Maintain Buy Buy
2022-11-07 Morgan Stanley Maintain Equal Weight Equal Weight
2022-09-14 Morgan Stanley Maintain Equal Weight Equal Weight
2022-09-14 Evercore ISI Group Upgrade In Line Outperform
2021-11-15 Morgan Stanley Maintain Equal Weight Equal Weight
2021-11-15 HC Wainwright & Co. Maintain Buy Buy
2021-10-19 Morgan Stanley Downgrade Overweight Equal Weight
2021-09-10 B of A Securities Maintain Buy Buy
2021-08-16 HC Wainwright & Co. Maintain Buy Buy
2021-03-23 Morgan Stanley Maintain Overweight Overweight
2021-03-23 HC Wainwright & Co. Maintain Buy Buy
2021-03-18 Canaccord Genuity Maintain Buy Buy
2021-03-17 Chardan Capital Maintain Buy Buy
2021-03-17 HC Wainwright & Co. Maintain Buy Buy
2021-02-26 Guggenheim Maintain Buy Buy
2020-11-25 Morgan Stanley Maintain Overweight Overweight
2020-11-25 Chardan Capital Maintain Buy Buy
2020-11-25 Jefferies Maintain Buy Buy
2020-11-25 HC Wainwright & Co. Maintain Buy Buy
2020-11-13 HC Wainwright & Co. Maintain Buy Buy
2020-09-10 Morgan Stanley Maintain Overweight Overweight
2020-07-20 HC Wainwright & Co. Maintain Buy Buy
2020-07-07 Chardan Capital Maintain Buy Buy
2020-07-01 HC Wainwright & Co. Maintain Buy Buy
2020-07-01 Jefferies Maintain Buy Buy
2020-03-02 H.C. Wainwright Maintain Buy Buy